Category

HIV/AIDS

Logo for the International AIDS Society's 2017 Scientific Meeting

International AIDS Conference 2017: We’ll see you in Paris

By | Fenway News, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
How can awareness of the efficacy of Pre-Exposure Prophylaxis (PrEP) be raised among gay men, who remain most vulnerable to HIV infection in the United States? What impact is mass incarceration in the U.S. having on the incidences of HIV? How does HIV look in the U.S. Southern and Northeast regions? Fenway-affiliated researchers and scientists have been studying these questions and four will travel to Paris for the International AIDS Conference being held July 23-26 to share what they are learning. They will be led by Kenneth H. Mayer, M.D., Medical Research Director and Co-Chair of The Fenway Institute, who 
Read More

Fenway Health Receives Major HRSA Grant To Improve HIV Outcomes

By | Fenway Health Newsroom, Health Care, HIV/AIDS, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
Fenway Health is pleased to announce that the Health Resources and Services Administration HIV/AIDS Bureau (HRSA/HAB) has awarded The Fenway Institute a groundbreaking four-year cooperative agreement ($5.325 million per year) to establish the Evidence-Informed Interventions Center for Coordinating Technical Assistance, focused on disseminating much-needed interventions for people living with HIV/AIDS. This national center is part of a new HRSA/HAB initiative entitled: “Using Evidence-Informed Interventions to Improve Health Outcomes for People Living with HIV/AIDS,” designed to identify and implement effective interventions for reducing HIV-related health disparities and improving health outcomes. Desired outcomes include increased retention in care, greater treatment adherence, and 
Read More

Announcing Dr. Kenneth Mayer As New Editor-In-Chief Of JIAS

By | Fenway Health Newsroom, Fenway News, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Fenway’s own Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the Journal of the International AIDS Society (JIAS). Dr. Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among his other accomplishments, he is the founding Medical Research Director of Fenway Health and Co-Chair of The Fenway Institute, a member of the US President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board, amfAR’s  Program Advisory Council, and a member of the International AIDS Society (IAS) Governing Council. “Ken is an extremely well respected clinician and researcher who I have had 
Read More

People with HIV, LGBT people, and Black and Latino people would disproportionately lose health insurance under the American Health Care Act

By | Health Care, Health Policy, HIV/AIDS, HIV/AIDS, LGBT Health, The Fenway Institute | No Comments
On May 24, the Congressional Budget Office (CBO) projected that the amended American Health Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 million Americans losing their health insurance by 2026 as compared with what would be expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). “It is clear from the CBO analysis that the amended Republican health care plan is no better than the original bill,” said Sean Cahill, Director of Health Policy Research at The Fenway Institute. “Of the 23 million Americans projected to lose their 
Read More

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More